Algorithm for comorbidities, associations, length of stay and mortality (ACALM)

被引:0
作者
Potluri, Rahul [1 ]
机构
[1] Aston Univ, Aston Med Sch, ACALM Study Unit, Birmingham B4 7ET, W Midlands, England
关键词
ACALM; big data; cancer; digital; future; hyperlipidemia; medicine; personalized; prospects; research; review; PSYCHIATRIC CO-MORBIDITIES; VASCULAR DEMENTIA; WORSE MORTALITY; UNITED-KINGDOM; RISK-FACTORS; ADMISSIONS; WEEKENDS; BURDEN; TRENDS; BREAST;
D O I
10.2217/fon-2018-0387
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The dream is personalized medicine and the ability to create a mechanism whereby using the data in big data groups such as ACALM, patients can be evaluated according to their characteristics and with a high degree of certainty, we can deliver patient-specific diagnostic and management options for their needs holistically.
引用
收藏
页码:1991 / 1994
页数:4
相关论文
共 40 条
[1]   Evidence-based medicine in a nutshell - A guide to finding and using the best evidence in caring for patients [J].
Bigby, M .
ARCHIVES OF DERMATOLOGY, 1998, 134 (12) :1609-1618
[2]  
Carter P, 2017, EUR HEART J, V38, P504
[3]  
Carter PR, 2016, EUR HEART J, V37, P303
[4]   HYPERLIPIDAEMIA REDUCES MORTALITY IN BREAST, PROSTATE, LUNG AND BOWEL CANCER [J].
Carter, Paul R. ;
Mcgowan, John ;
Uppal, Hardeep ;
Chandran, Suresh ;
Sarma, Jaydeep ;
Potluri, Rahul .
HEART, 2016, 102 :A57-A58
[5]  
CHILTON NW, 1974, J PERIODONTAL RES, P207
[6]  
Coile R C Jr, 2000, Physician Exec, V26, P8
[7]  
Delrose DC, 1999, J AM DENT ASSOC, V131, p57S
[8]   The Cochrane Collaboration: Evaluation of health care and services using systematic reviews of the results of randomized controlled trials [J].
Dickersin, K ;
Manheimer, E .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1998, 41 (02) :315-331
[9]  
Dowlut MS, 2009, EUR J GYNAECOL ONCOL, V30, P562
[10]  
Fleming A, 1944, Ulster Med J, V13, P95